Importantly, HCC is a type of refractory cancer with predominant c-Myc overexpression (Xu et al., 2019), and the proliferation of HCC can be inhibited with a low concentration of CUDC-907, as suggested by the aforementioned results. The gene discussed is MYC; the disease is hepatocellular carcinoma.